Status:
UNKNOWN
Clinical Characteristics of Lung Cancer in China
Lead Sponsor:
Shanghai Pulmonary Hospital, Shanghai, China
Conditions:
Lung Cancer
Eligibility:
All Genders
Brief Summary
This study is a single-center, real-world and large-population-based retrospective study. In the current study, the investigators not only describe the changes of demographic and basic clinicopatholog...
Detailed Description
In this study, the investigators will collected all lung cancer patients diagnosed in Shanghai Pulmonary Hospital from 2012 to 2020. By conducting this population based study, the investigators would ...
Eligibility Criteria
Inclusion
- Patients have medical records in our hospital.
- Patients were diagnosed as lung cancer by pathological examination.
Exclusion
- Patients were lack of accurate pathological diagnoses.
- Pathological diagnosis was benign disease or metastatic cancer from other organs.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
119785 Patients enrolled
Trial Details
Trial ID
NCT05423236
Start Date
July 1 2022
End Date
June 30 2023
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China, 200433